Search results
Results From The WOW.Com Content Network
Myc is a family of regulator genes and proto-oncogenes that code for transcription factors. The Myc family consists of three related human genes: c-myc , l-myc , and n-myc . c-myc (also sometimes referred to as MYC) was the first gene to be discovered in this family, due to homology with the viral gene v-myc.
Rearrangement of dimers (e.g., Mad:Max, Max:Myc) provides a system of transcriptional regulation with greater diversity of gene targets. Max must dimerise in order to be biologically active. [7] Transcriptionally active hetero- and homodimers involving Max can promote cell proliferation as well as apoptosis. [8]
Specifically, two biogenesis regulators—PGC1α and c-Myc—can be targeted to prevent cancer proliferation. PGC1α is a key component in mitochondrial biogenesis—as a transcriptional coactivator, it targets multiple transcription factors and the estrogen-related receptor alpha (ERRα). [25]
In molecular biology and genetics, transcriptional regulation is the means by which a cell regulates the conversion of DNA to RNA (transcription), thereby orchestrating gene activity. A single gene can be regulated in a range of ways, from altering the number of copies of RNA that are transcribed, to the temporal control of when the gene is ...
The MYCN gene is a member of the MYC family of transcription factors and encodes a protein with a basic helix-loop-helix domain. This protein is located in the cell nucleus and must dimerize with another bHLH protein in order to bind DNA. [5] N-Myc is highly expressed in the fetal brain and is critical for normal brain development. [6]
This process is mediated through canonical Wnt signaling, which increases nuclear and cytoplasmic β-catenin. Increased β-catenin can initiate transcriptional activation of proteins such as cyclin D1 and c-myc, which control the G1 to S phase transition in the cell cycle.
transcriptional regulation – controlling the rate of gene transcription for example by helping or hindering RNA polymerase binding to DNA; upregulation, activation, or promotion – increase the rate of gene transcription; downregulation, repression, or suppression – decrease the rate of gene transcription
Thus, the products of most oncogenes such as Jun, Fos, Myc, [11] [12] the Yamanaka factors namely, OCT3/4, SOX2, MYC, NANOG, and KLF4 that induce reprogramming of pluripotent stem (iPS) cells, [13] and >90% of the Cancer/Testis Antigens [14] several of which are implicated in EMT [15] [16] are predicted, and in many cases experimentally ...